Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

The Dose Matters: Optimizing Statin Intensity in ASCVD Management
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
MinuteCE®
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Target in Sight: Escalating Therapy to Reach LDL-C Goals
Target in Sight: Escalating Therapy to Reach LDL-C Goals
MinuteCE®
Target in Sight: Escalating Therapy to Reach LDL-C Goals
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
MinuteCE®
From Risk to Results: Cases in ASCVD Prevention and Treatment
1.00 credit 10 episodes
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 credit 10 episodes
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
MinuteCE®
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
1.00 program credit
- Rishi Wadhera, MD, MPP, Mphil
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
1.00 program credit
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
MinuteCE®
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Bridging ASCVD Care Between Academic and Rural Settings
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®
Bridging ASCVD Care Between Academic and Rural Settings
1.00 program credit
- Rishi Wadhera, MD, MPP, Mphil
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
1.00 program credit
Albuminuria Change and Finerenone's Effect on CV Outcomes
Albuminuria Change and Finerenone's Effect on CV Outcomes
CME/CE
Albuminuria Change and Finerenone's Effect on CV Outcomes
- Finnian R. McCausland, MD

Programs

Statins and Safety: What the Data Say About Dementia, Cancer, and More
Statins and Safety: What the Data Say About Dementia, Cancer, and More
MinuteCE®
Statins and Safety: What the Data Say About Dementia, Cancer, and More
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
MinuteCE®
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Topline Results of the CONFIDENCE Trial
Topline Results of the CONFIDENCE Trial
CME/CE
Topline Results of the CONFIDENCE Trial
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
The CONFIDENCE Trial: Data Insights
The CONFIDENCE Trial: Data Insights
CME/CE
The CONFIDENCE Trial: Data Insights
- prof. Hiddo Heerspink
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CE
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
0.25 credits
- prof. Hiddo Heerspink
- Jennifer B. Green, MD
0.25 credits
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CE
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
- Piotr Ponikowski, MD, PhD, FESC, FHFA
0.25 credits
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Heart Matters
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
- Michelle Kittleson, MD, PhD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Tailoring Treatment for Optimal Outcomes in Patients With AAV
MinuteCE®
Tailoring Treatment for Optimal Outcomes in Patients With AAV
0.75 program credits
- Bernhard Hellmich, MD
- Andreas Kronbichler, MD
0.75 program credits

Clinical Practice

When and Why to Use CAC Scoring
When and Why to Use CAC Scoring
MinuteCE®
When and Why to Use CAC Scoring
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 credit
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
- Stefan D. Anker, MD, PhD
- Mahir Karakas, MD, PhD, MBA
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
- John Ostrominski
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
- Akshay S. Desai, MD
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
- Jonathan Cunningham, MD
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD

CME

Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Elevating Care for Patients With Severe Renal Disease in AAV
Elevating Care for Patients With Severe Renal Disease in AAV
MinuteCE®
Elevating Care for Patients With Severe Renal Disease in AAV
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
MinuteCE®
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
0.75 credits 6 episodes
- Bernhard Hellmich, MD
- Andreas Kronbichler, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 credits 6 episodes
Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Don't Miss It! Rapid & Accurate AAV Diagnosis 
Don't Miss It! Rapid & Accurate AAV Diagnosis 
MinuteCE®
Don't Miss It! Rapid & Accurate AAV Diagnosis 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
MinuteCE®
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Optimizing AAV Outcomes: Maintenance Therapies
Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®
Optimizing AAV Outcomes: Maintenance Therapies
0.75 program credits
- Bernhard Hellmich, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 program credits